Generics UK-based drug delivery specialist SkyePharma (LSE: SKP) has appointed Pierre Delavaud as executive vice president, sales and business development, at the company's main R&D facilities in Muttenz, Switzerland. Dr Delavaud has more than 17 years of experience in the pharmaceutical industry, with a strong track record in marketing, sales and global business development of which 14 years have been with the Catalent Group (and its preceding companies). Until recently he was VP sales and business development global pharmaceutical at Softgel. 7 September 2011